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MODIFIED COMPREHENSIVE BEHAVIORAL INTERVENTION FOR TICS: 
TREATING CHILDREN WITH TIC DISORDERS, CO-OCCURRING ADHD, 
AND PSYCHOSOCIAL IMPAIRMENT 
CAROLINE ALBRIGHT 
ABSTRACT 
Objective: To evaluate the feasibility and acceptability, and preliminary efficacy of 
Modified Comprehensive Behavioral Intervention for Tics (MCBIT) therapy for patients 
with persistent chronic tic disorders (CTD) and co-occurring attention deficit 
hyperactivity disorder (ADHD).  
Method: Seventeen child and adolescent patients aged 10-17 with CTD and co-occurring 
ADHD were randomly assigned to the MCBIT group (n=9) or to a control group, where 
they received traditional Comprehensive Behavioral Intervention for Tics (CBIT) therapy 
(n=8). Both groups received ten fifty-five-minute weekly treatment sessions, and two 
fifty-five-minute biweekly relapse prevention sessions.  
Results: Sixteen of the seventeen participants completed the study, and acceptability 
ratings in both treatment groups were high with no significant differences in expectation 
of improvement. The MCBIT and CBIT groups in combination showed significant 
improvement in measures of tic severity, ADHD symptom severity, and tic impairment 
and group differences were not statistically significant. 
vi 
Conclusion: The results indicate that MCBIT treatment is feasible and acceptable for 
youth with CTD and ADHD, and the findings demonstrate preliminary support for the 
modified CBIT treatment’s efficacy in reducing tic and ADHD symptoms and improving 
tic-related quality of life. Additional studies with more participants are warranted to 
further examine the role of a modular behavioral treatment approach in targeting 
commonly co-occurring disorders simultaneously and successfully. 
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Background of Tic Disorders 
Tic disorders, such as Tourette syndrome (TS) and persistent motor or vocal tic 
disorders (PMVT) (together henceforth CTD), are developmental neuropsychiatric 
disorders that consist of multiple motor or vocal tics that persist for at least one year. 
CTD affect about ~2% of the population (Scahill et al., 2014 and Scharf et al., 2015). 
Tourette Syndrome (TS) is a neuropsychiatric syndrome with childhood-onset 
characterized by the presence of motor and vocal tics. To meet DSM-5 criteria for TS, 
one must have at least two motor tics (e.g. blinking, shoulder shrugging) and at least one 
vocal tic (e.g. coughing, throat clearing) that occur for at least one year, and are not 
secondary to another medical condition or medication (American Psychiatric Association 
[APA], 2013). The criteria for persistent motor or vocal tic disorders (PMVT) are similar 
to that of TS, except that the individual has to have either motor or vocal tics (American 
Psychiatric Association [APA], 2013). Studies have shown up to 90% of individuals with 
TS have co-occurring conditions, with at least 50% having co-occurring ADHD 
(Hirschtritt et al., 2015 and Specht et al., 2011). Tic disorders are often associated with 
significant psychosocial consequences, including reduced self-esteem and reduced 
quality of life (Rowe et al., 2013 and Storch et al., 2007). Youth with TS and their parents 
also frequently report impairments in daily functioning, which is characterized by the 
inability to perform age-appropriate tasks in various domains including school, home and 
social. (Storch et al 2007).  In youth with CTD, additional ADHD symptoms associate 
with increased social difficulties, decreased quality of life, and greater 
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psychopathological impairment (McGuire et al., 2013, Storch et al., 2007, El Malhany et 
al. and McGuire et al., 2015). In general, the presence of co-occurring disorders 
negatively impacts quality of life in those with CTD more than increased tic severity 
alone (Eddy et al., 2011 and Zhu et al., 2006). Storch et al. found that ~70% of the 
problems experienced by those with chronic tic disorders were non-tic related, typically 
secondary to ADHD or OCD (Storch et al., 2007). The 2018 Impact Survey from the 
Tourette Association of America reported that 36% of adults and 42% of children felt the 
greatest challenge of living with TS was having to manage the co-occurring conditions 
and both groups shared the second greatest challenge was the limited medication and 
treatment options available (“Impact Survey”, 2018).  See Figure 1 for overview of 
parent-reported challenges associated with TS in youth.  
 
 




Background of CBIT Therapy 
Comprehensive behavioral intervention for tics (CBIT) is a behavioral therapy 
specifically designed for the treatment of tics. The CBIT model was first published in 
2010, and is now considered a first-line treatment for those with tic disorders (Piacentini 
et al., 2013 and Scahill et al., 2013). CBIT blends components of habit reversal therapy 
(HRT), including awareness training, competing response development and relapse 
prevention, with relaxation techniques and function-based intervention (where contextual 
factors that support or maintain tic expression are assessed and addressed). Of note, CBIT 
can be challenging for those ten and under as they have difficulty detecting the 
“premonitory urges” that are key to the awareness training component of CBIT (McGuire 
et al., 2014 and Woods et al., 2005). That said, more recent studies have called this 
supposition into question and have successfully enrolled children as young as nine into 
CBIT therapy trials with no significant difference in outcome for those under ten 
(Ricketts et al., 2018). While very effective in tic reduction, CBIT tends to be “tic-
specific” (Woods et al., 2011, p.863). In a study comparing CBIT to psycho-
education/supportive therapy, CBIT did not result in differential changes to co-occurring 
psychiatric symptoms and/or psychosocial functioning (Woods et al., 2011). A cognitive 
behavioral therapy (CBT)-based program, called “Living with Tics” (LWT) specifically 
targeted the psychosocial and functional impairment associated with CTD (Storch et al 
2012) by providing coping skills and promoting resiliency. In a small randomized 
controlled trial (RCT), they found that the LWT treatment was acceptable, and associated 
with significantly improved quality of life, in addition to reduced Yale Global Tic 
 
4 
Severity Scale (YGTSS) tic-related impairment (McGuire et al., 2014, McGuire et al., 
2015 and Storch et al., 2012). Regarding tic reduction, The LWT group did not differ 
from the waitlist group.  
While CBIT is generally effective in reducing tics, there is some evidence that the 
presence of co-occurring ADHD negatively moderates the effect of the behavioral 
treatment in those with CTD, and overall (McGuire et al., 2014 and Halldorsdottir et al., 
2015). Hypotheses for this finding include symptoms of ADHD impeding one’s ability to 
engage in the therapy session, and/or the ADHD symptoms themselves (e.g. inattention, 
impulsivity) negatively impacting tic suppression (McGuire et al., 2014). That said, there 
has recently been more mixed data as a recent analysis concluded that “the presence of 
ADHD did not moderate treatment effect in participants under 18 years old” in either the 
CBIT or psychoeducation and supportive therapy groups (Sukhodolsky et al., 2017). 
Further research will be helpful in elucidating why ADHD symptoms appear to moderate 
change in some studies but not others.  
Regardless, evidence shows that behavioral treatments can indeed be effective for 
improving ADHD symptoms (Antshel et al., 2014, Fabiano et al., 2009, Gould et al 
2018., Safren et al., 2005, and Sprich et al., 2012, Sprich et al 2016), particularly when 
there are residual symptoms after pharmacological treatment. Approximately 5% of the 
school-age population is affected by ADHD which is characterized by a combination of 
hyperactive, impulsive, and inattentive symptoms that lead to impairment in at least two 
settings (e.g. school, family, social) (Kofler et al., 2019). Approximately 40-75% of those 
with ADHD experience emotional lability such as low frustration intolerance, impatience, 
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quickness to anger, and excitability. Additionally, executive dysfunction is common in 
the ADHD population, with 90% of those with ADHD experiencing some form of 
executive dysfunction such as disinhibition, difficulties with working memory, and 
reduced organization and planning ability (Kofler et al., 2019). Stimulant medication is 
the gold standard treatment in ADHD, and in school-aged youth, is recommended as the 
first line of treatment. There is also evidence that behavioral treatment can help improve 
ADHD-associated symptoms, particularly when used in conjunction with stimulant 
medication (“A 14-month randomized clinical trial of treatment strategies for ADHD”, 
1999).  
Regarding behavioral therapy treatment approaches, there are precedents for 
modifying and combining treatment protocols to better target specific populations. In 
2015, Scribberas et al modified a CBT protocol for anxiety to account for co-occurring 
ADHD symptoms (Scriberras et al 2015), and Jarrett and Ollendick (2012) successfully 
combined treatment protocols to improve outcomes in youth with co-occurring ADHD 
and anxiety. Ricketts et al (2015) demonstrated that modifying the CBIT protocol to six 
twenty minutes sessions was feasible and acceptable and resulted in improved tic 
symptoms.  
Given the high rates of comorbid psychiatric diagnoses in youth, there has a been 
a recent push towards tailoring behavioral treatments more towards the individual patient 
and their particular symptom profile rather than a specific diagnosis. This has been 
achieved through the development of modular treatment protocols, where the clinician 
selects the module(s) most appropriate for the patient (McGuire et al., 2014; Thomas et 
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al., 2020; Wilhelm et al., 2011; Wood et al., 2014). Jeppesen et al. developed a 
transdiagnostic, modular CBT approach that demonstrated increased reduction in anxiety 
and depressive symptoms compared to typical CBT, and resulted in reduced impact of 
symptoms as reported by parents (Jeppesen et al., 2020). A modular approach to 
behavioral therapy has also demonstrated preliminary effectiveness in those with tic 
disorders and co-occurring oppositional defiant disorder (ODD). It is estimated that 25-
65% of those with tic disorders have co-occurring ODD (Espil, 2020). Espil et al 
developed a process in treating co-occurring tics disorders and ODD that allowed 
therapists to match treatment modules to individual client’s profiles, thus providing a 
customized approach to therapy (Espil, 2020).  
Another novel approach to behavioral treatment delivery is the Unified Protocol 
for Transdiagnostic Treatment of Emotional Disorders. This protocol, which combined 
elements from the treatment of multiple disorders was shown to be at least as effective as 
traditional single-disorder protocols used to treat specific anxiety disorders (Barlow et al., 
2017). Training clinicians to provide single protocol therapy that simultaneously targeted 
common co-occurring disorders was demonstrated to be at least as efficacious as single 
diagnosis protocols, and was noted to be more efficient and cost-effective. Additionally, 
the transdiagnostic approach demonstrated less attrition compared to the single diagnosis 
protocol group (Barlow et al., 2017).  
Currently, there is no standardized behavioral treatment for CTD that accounts for 
ADHD symptoms and/or addresses the impact that ADHD symptoms have on tic-related 
behavioral treatment or quality of life. Given the high rates of comorbidities in tic 
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disorders, including ADHD, the ability to treat tic and non-tic related symptoms and 
impairments concurrently would be paramount. 
 
Goals of the Present Study 
The purpose of this study was to address the gap in treatment availability, and 
develop a model within the effective CBIT-framework that directly addresses ADHD 
symptoms. We hypothesized that modifying the current CBIT protocol would be feasible 
and acceptable to participants, and would demonstrate efficacy in the treatment of tics, 
ADHD, and quality of life measures in those with CTD and co-occurring ADHD.  
 
Specific Aims 
1) The primary aim of this study was to determine the treatment feasibility and 
acceptability of a modified CBIT (MCBIT) protocol for children and adolescents with 
CTD and ADHD.  
2) The secondary aim was to evaluate preliminary changes in tic, ADHD and quality of 
life symptoms using the Yale Global Tic Severity Scale (YGTSS), NICHQ 
Vanderbilt Assessment Scales (VAS), Pediatric Quality of Life Inventory-Child 
Version (PedsQL) scale, and Clinical Global Impression (CGI) scales as rated by a 







 Participants included in the study were children and adolescents aged 10-17 years 
with diagnoses of CTD and co-occurring ADHD. Seventeen youths were enrolled and 
randomized to either the modified CBIT condition (MCBIT) or control group (CBIT). 
Inclusion criteria were: ages 10-17 years (inclusive), a primary diagnosis of TS or PMVT 
with a secondary diagnosis of ADHD using the DSM-5 criteria, a YGTSS of >13 (or >9 
if PMVT), total impairment score of >19 on the YGTSS, English speaking, and ability to 
communicate meaningfully with the investigators and provide written assent.  
Exclusion criteria were additional co-occurring psychiatric diagnoses including 
alcohol or substance abuse within the past three months, psychosis, current mania, 
organic mental disorder, developmental delay, IQ <80 on the Wechsler Abbreviated 
Scale of Intelligence (WASI), or any cognitive or communication impairment that would 
preclude the participant from effectively engaging in CBT. Additional exclusion criteria 
included active suicidality within the past six months, current severe illness warranting 
immediate psychopharmacological evaluation or intervention, any clinical features 
requiring a higher level of care than outpatient treatment as determined by the evaluator, 
other concurrent psychotherapy (decisions made on a case by case basis depending on 
what the additional therapy was targeting), and four or more previous CBT or CBIT 
treatment sessions within the last five years. Receiving psychotropic medication was not 
cause for exclusion, but participants were required to maintain a stable dose for four 
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weeks prior to the baseline assessment, and were required to maintain this dosage 
throughout the duration of the study.  
Over the course of the study, certain inclusion and exclusion criteria were 
amended in order to increase recruitment and limit attrition including: broadening the age 
range from 11-17 to 10-17, allowing the follow-up assessments to be conducted via 
telephone, allowing participants to continue in the study if there was a gap in treatment  
greater than two weeks, requiring patients to be on a steady dose of medication for four 
weeks rather than six, allowing those with a diagnosis of autism spectrum disorder (ASD) 
to enroll so long as they were able to communicate effectively, and relaxing the criteria of 
having a current clinically active diagnosis of ADHD to having a documented formal 
history of ADHD with ongoing persistent symptoms (as per DSM-V criteria).  
Demographics of the participants and their parents as well as psychiatric 
comorbidities and medication usage are presented in Table 1. Participants were 
randomized based on sex and presence/absence of prescribed psychotropic medication. 
Participants ranged in age from 10 to 17 years and the majority of participants were male 
(82.3%). Most of the participants identified as Caucasian (71%). A majority of 
participants’ parents (88%) had an annual income that exceeded $100,000. All 
participants were previously diagnosed with a co-occurring psychiatric disorder other 
than Tourette Syndrome and ADHD. The most common co-occurring disorders included 
obsessive-compulsive disorder (OCD; 59%), anxiety disorder (47%), and oppositional 
defiant disorder (ODD; 35%).  
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Over half of participants (53%) were currently taking a psychotropic medication 
with the most commonly taken being alpha agonists (29%), antidepressants (29%), and 
stimulants (24%).  
 




 Study procedures and all recruitment materials were approved and monitored by 
the Partners Institutional Review Board for human subjects research. Participants were 
mean/N (SD)/% mean/n (SD)/% mean/N (SD)/%
Demographics (Child)
Age, mean (SD) 13 2 2.4 13.3 1 8
Male Gender, N (%) 7 78% 7 88% 14 82%
White 7 78% 5 63% 12 71%
Asian 0 0% 1 13% 1 6%
More than one race 1 11% 2 25% 3 18%
Other 1 11% 0 0% 1 6%
Demographics (Parents)
Income, N (%) 1 11% 0 0% 1 6%
$25,000-49,000 0 0% 1 13% 1 6%
$50,000-74,999 5 56% 3 38% 8 47%
$100,000-200,000 3 33% 4 50% 7 41%
>$200,000
Psychiatric Comorbidities (Child)
DSM-V Axis I Diagnoses, N (%)
ADHD, Combined 6 67% 4 50% 10 59%
ADHD, Inattentive Type 3 33% 2 25% 5 29%
ADHD, Hyperactive/Impulsivity Type 0 0% 2 25% 2 12%
ADHD, Unspecified 0 0% 0 0% 0 0%
Anxiety Disorder (generalized, social, separation, mixed) 3 33% 5 63% 8 47%
Major Depressive Disorder/Mood Disorder (inc. dysthymia) 2 22% 0 0% 2 12%
Obsessive-compulsive disorder 4 44% 6 75% 10 59%
Oppositional Defiant Disorder 2 22% 4 50% 6 35%
Any Axis 1 disorder (outside of TS/ADHD) 9 100% 8 100% 17 100%
Current Psychotropic Medication Use (Child)
Any, N (%) 5 56% 4 50% 9 53%
Alpha agonist, N (%) 2 22% 3 38% 5 29%
Antidepressant, N (%) 2 22% 3 38% 5 29%
Antipsychotic, N (%) 0 0% 3 38% 3 18%
Mood stabilizer or anticonvulsant, N (%) 1 11% 2 25% 3 18%









recruited from April 2016 to March 2019 and were informed about the study by clinicians 
in the OCD and Related Disorders Clinic, the Child Psychiatry Outpatient Clinic, the 
Neurology Tic Disorders Clinic, and the Pediatric Neuropsychiatry and Immunology 
Clinic at Massachusetts General Hospital (MGH).  Participants were also informed about 
the study through local symposia on TS and related disorders and via fliers posted at 
MGH and local community restaurants, coffee shops, etc.  
Eligibility criteria were assessed via a phone-based interview. Those that were 
deemed appropriate to enroll were asked to attend a pre-treatment assessment session in 
which the study procedures were explained and assent and informed consent were 
obtained (by a study representative or Dr. Greenberg). If Dr. Greenberg found the 
potential participant to be eligible following the baseline assessment, they were brought 
back in for their first treatment session where they were enrolled and immediately 
randomized to the MCBIT or control group. Subjects were not told which group they had 
been placed in; however, given the difference in materials presented in treatment 
sessions, some participants were likely able to determine their group. The treater was not 
blinded to which group subjects had been placed, but the independent evaluator who 


















Assessment and Measures 
Assessments were conducted at baseline, the mid-point of treatment (after the 6th 
session), the end of treatment (EOT) (after the 12th session), and at the 3-month follow-up 
mark. Additionally, participants and the treatment therapist completed weekly scales (see 
Table 2). Baseline only measurements included: Mini International Neuropsychiatric 
Interview for children and Adolescents (MINI-KID), the Wechsler Abbreviated Scale of 
Intelligence (WASI) and the Client Expectancy Rating (CER). Ongoing measurements 
included the Yale global Tic Severity Scale (YGTSS), NICHQ Vanderbilt Assessment 
Scale (VAS), Clinical Global Impression-Improvement (CGI-Improvement), Clinical 
Global Impression-Severity (CGI-Severity), Pediatric Quality of Life Inventory-Child 
Version (PedsQL), Likert Scales/Open-Ended Questions (regarding the 
satisfaction/effectiveness of each session), and the Concomitant Medication and Therapy 
Questionnaire (Concom). The Client Satisfaction Questionnaire (CSQ – Satis) was given 
at the mid-point and end of treatment. Other scales collected included the Children's 
Depression Inventory (CDI), Caregiver Strain Questionnaire (CSQ), Child Tourette's 
Syndrome Impairment Scale (CTIM-P), Children's Yale-Brown Obsessive-Compulsive 
Scale (CY-BOCS), Emotion Regulation Questionnaire for Children and Adolescents 
(ERQ-CA), and the Parent Tic Questionnaire (PTQ). The baseline assessment scales were 
collected by study staff of at least a Bachelor's level education prior to subject 
randomization. Mid-point and post-treatment assessments were collected by Master's 
level or highly trained Bachelor's level study staff. See Appendix A for summary of 
individual assessment scales. 
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Table 2. Assessment Measure Administration Schedule  
Measures Rater Self   Screen Baseline Weekly 
Mid-
Point Final Session 3-month f/up 
YGTSS X     X X 
 
  X X X 
VAS - ADHD X     X           
VAS - Abbrev   X     X   X X X 
ADHD - SR   X     X   X X X 
MINI-KID X       X         
CTIM   X     X   X X X 
PedsQL   X     X   X X X 
PTQ   X     X   X X X 
CGI-I X X        X  X X X 
CGI-S X       X X X X X 
CSQ-8   X     X    X X X 
CER   X     X   X     
WASI X       X         
Likert   X       X X X   
CY-BOCS X       X   X  X X 
CSQ-Satis.   X         X  X X 
ERQ-CA   X     X   X X X 
CONCOM X       X X X X X 
CDI   X     X   X X X 
 
 
Primary Outcome Measures 
 The primary aim of the study was to determine the treatment feasibility and 
acceptability of the developed MCBIT protocol. The primary measures used to assess this 
aim were the Client Satisfaction Questionnaire (CSQ-Satis) and the Client Expectancy 
Rating (CER). The CSQ-Satis is an eight question, four-point Likert self-report scale that 
measures satisfaction with treatment. The CER is also a four-point self-report 
questionnaire that assesses patient’s judgements about the credibility of the treatment 
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rationale, expectancy of change, and treatment acceptability. Additionally, patient 
retention and attrition were evaluated to assess treatment feasibility and acceptability.  
Secondary Outcome Measures 
 The secondary aim of this study was to pilot test the effectiveness of the MCBIT 
treatment protocol in youth with tic disorders and co-occurring ADHD. The secondary 
measures used to assess this aim were the Yale Global Tic Severity Scale (YGTSS), the 
NICHQ Vanderbilt Assessment Scale (VAS), the Pediatric Quality of Life Inventory-
Child Version (PedsQL), and the CGI-I clinician-rated scale. The YGTSS is a clinician-
rated semi-structured interview that measures tic symptom severity over the previous. 
The YGTSS has two separate components including a Total Tic Score (range: 0-50), and 
a Total Impairment Score (range: 0-50) with higher ratings corresponding to greater tic 
severity and impairment. The VAS is a parent rated scale that includes the DSM-IV 
symptom list for ADHD and other externalizing behaviors, including oppositional defiant 
disorder and conduct disorder (CD). VAS is measured on a 4-point scale which ranges 
from 0 (not at all) to 3 (very much). PedsQL is a twenty-three-item child-rated scale that 
measures a youth’s quality of life. Each item is rated on a five-point scale, with higher 
scores indicating better quality of life. The CGI-Improvement is a seven-point Likert 
scale indicating any changes in overall mental health status and ranges from very much 




The MCBIT treatment was based on the original CBIT protocol (Piacentini et al., 
2010), CBT for ADHD in adolescents protocol (Sprich et al., 2016), some elements of 
"Living with Tics" (Storch et al., 2012 and McGuire et al., 2014), and common cognitive 
behavioral therapy (CBT) techniques (e.g. thinking errors) broadly aimed at improving 
quality of life. Ten fifty-five-minute weekly sessions were conducted, followed by two 
relapse prevention sessions spaced two weeks apart. Individuals in both the CBIT and 
MCBIT group were provided with a tracking binder for CBIT-related hand-outs. Both 
groups completed weekly tic hierarchies, were assigned homework at the end of each 
session, and participated in a behavioral reward program. Both groups were taught the 
three core components of CBIT, including functional behavior assessment and 
intervention, habit reversal therapy, and relaxation training. In almost all cases, at least 
one parent participated in the sessions throughout the entirety of the treatment. Parents 
would step out of the room upon request from the participant for any particularly 
sensitive topics.  
Participants in the MCBIT group received additional hand-outs including session 
outlines and summaries, visual aids during the sessions, and homework reminders. In 
addition, MCBIT subjects had access to fidget toys in the treatment room and were given 
one minute "brain breaks" between session activities. The treatment plan for both groups 
was divided into three phases: Evaluation/Psychoeducation, Basic Intervention, and 
Relapse Prevention for a total of twelve sessions. Both groups received a binder with 
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blank session-related handouts at the end of the treatment, and were given the opportunity 
to provide feedback about the treatment process. 
 
Summary of MCBIT treatment sessions: 
Evaluation/Psychoeducation (Session 1): The first session primarily focused on 
assessing the subject's tics and ADHD symptoms as well as the impact of tics and ADHD 
on their life. The therapist created a tic hierarchy with the patient to determine which tics 
were most bothersome. Psychoeducation about tics/Tourette Syndrome and ADHD, as 
well as CBIT and CBT models were provided to participants in an age-appropriate 
manner. The idea of function-based interventions, as well as planning and organization 
skills, were introduced  
Basic Interventions (Session 2-10): These sessions focused on teaching CBIT 
principles, CBT for ADHD principles, and other general CBT techniques aimed at 
improving quality of life. Each session included review of homework from the previous 
session, review of current symptoms, and at least some time focusing on CBIT principles. 
Two sessions were dedicated solely to CBIT, and included additional elements of parent 
guidance (Ricketts et al., 2015). Three sessions focused on common ADHD symptoms 
(such as organization, planning, and distractibility) and treatment techniques. Four 
sessions focused on other common challenges typically affecting youth with co-occurring 
tic disorders and ADHD, such as emotion dysregulation, self-esteem and anxiety/thinking 
errors. Hand-outs describing topics covered during each session were provided to the 
participant/parent(s) at the conclusion of the session.  
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Relapse Prevention (Session 11-12): The final two sessions were held at two-
week intervals beginning two weeks after the final intervention session, and focused on 
relapse prevention. During these sessions, the treater focused on transitioning the role of 
‘therapist’ to the participant. Concerns about ending treatment and what to expect in the 
future were addressed. All skills learned over the course of the treatment were reviewed, 
and rated regarding degree of helpfulness. Strategies for continuing to practice the skills 
learned during the treatment were reviewed.  
 
ASAP Sessions 
 The protocol was amended to include the addition of extra Adjunctive Services 
and Attrition Prevention (ASAP) sessions to address crises and/or unusual needs or 
circumstances that arose. The goal of these sessions was to increase subject retention and 
each subject was allowed up to three ASAP sessions. Any subject that required more than 
the three allotted ASAP sessions was no longer considered eligible and terminated from 
the study. Two subjects utilized ASAP sessions.  
 
Adverse Events 
 Adverse events were monitored throughout the course of the study. The provider 
assessed for tic worsening, new health complaints, or behavioral changes during each 
treatment visit. Any replies indicating a possible adverse event prompted further inquiry 
and steps were taken to document and address it. Three subjects experienced adverse 
events. One subject reported tic and ADHD symptoms that were “very much worse” at 
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therapy session five, while one subject’s parent reported a drop in mood and requested an 
ASAP session. Both subjects were monitored and assessed at their subsequent sessions 
and determined to not be at risk of harm and were able to continue in the study. The third 
subject reported feeling ill and rescheduled an assessment for a later time. 
 
Statistical Analysis  
 All statistical analyses were conducted using SASS software. In all tests 
conducted, values of P<.05 were considered to be statistically significant. All outcome 
measures were modeled as repeated measures mixed models with treatment-group and 
time as predictors. Repeated measures were modeled using a Toeplitz covariance 
structure with heterogenous variances. Specific contrasts were used to test hypotheses 
about overall treatment effects from baseline to EOT, treatment differences over time by 
EOT, and treatment effects from baseline to EOT within each treatment group. All 
analyses were done according to the Intention-to-Treat (ITT) principle including all 










 Following randomization, the retention rate was strong, with sixteen of the 
seventeen participants completing the study. The participant who elected to discontinue 
did so secondary to logistical difficulties. All other participants were able to attend all 
treatment and follow-up sessions as scheduled. Of note, final assessments were changed 
from in-person to via phone for a handful of the participants (n=4) in order to ease burden 
of traveling to Boston for a non-treatment appointment.   
 
Primary Outcome: Feasibility and Acceptability  
 Participants in both the MCBIT and CBIT groups expressed high levels of 
satisfaction with the treatment protocol. There was no significant difference in the Client 
Satisfaction Questionnaire (CSQ-Satis) ratings between groups, and both groups trended 
towards improved satisfaction over time (p=0.18) with the MCBIT group improving from 
27.0/30 to at midpoint to 28.75/30 at end of treatment, and the CBIT group improving 
from 27.75/30 at midpoint to 29.29/30 at end of treatment. The majority of participants 
expected to improve, expressed satisfaction with the treatment, and were optimistic about 
their outcomes. There was no significant difference in the Client Expectancy Rating 
(CER) score between groups, and both groups’ expectation of improvement (on a scale of 




Secondary Outcomes: Treatment Effectiveness  
 Summary statistics including means (M), standard deviations (SD) and within-
group effect sizes for all secondary measures for both groups are reported in Table 3.  
 
Table 3. Summary Statistics of Secondary Measures  
 
 
YGTSS Total Tic Severity  
YGTSS tic severity scores demonstrated statistically significant improvement by 
end of treatment (EOT) when looking at the CBIT (control) and MCBIT groups in 
combination (pre: M=32.3, SD=9.64; post: M=26.4, SD=8.48; p=0.005, dws=-0.61). 
There was significant improvement in tic severity in the control group (p=0.016, dws=-
0.81) and a trend towards significant improvement in the MCBIT group (p=0.085, dws=-
0.53), though the treatments did not significantly differ from one another over time 
(p=0.572, dIGPP=.28). These changes in tic reduction were maintained and strengthened 
over time by follow-up in both groups, particularly in the MCBIT group (within-group 
effect sizes: control dws=-0.93, MCBIT dws=-1.13), though the group differences were 




Variable Group M SD M SD M SD
YGTSS Total Severity MCB T 29 22 10 24 23 75 10 17 17 63 8 9 -1 13
CB T 35 75 8 17 29 13 5 84 28 14 4 74 -0 93
YGTSS Total impairment MCB T 28 89 7 82 13 75 11 88 12 5 12 82 -2 1
CB T 31 25 9 91 22 5 10 35 21 43 10 69 -0 99
Vanderbilt (ADHD total score) MCB T 28 67 8 73 22 63 7 33 20 43 7 83 -0 94
CB T 24 5 8 93 17 38 9 77 20 10 02 -0 5
PEDQL (Child-Rated) MCB T 73 78 5 62 73 23 10 29 82 1 11 85 1 48
CB T 68 48 8 13 66 08 12 42 69 67 11 19 0 15









In this study, we evaluated the acceptability and feasibility of a modified CBIT 
treatment that accounts for co-occurring ADHD symptoms and worse quality of life in 
youth with CTD and co-occurring ADHD, as well as present new preliminary data on the 
efficacy of this modified CBIT treatment.  
The results of this study indicate that MCBIT was both feasible and acceptable. 
There was an unusually high retention rate (94%), and the attrition rate of 6% was lower 
than other typically reported rates in small scale (n<50) behavioral therapy studies, such 
as 12.5 % (Jarrett and Ollendick, 2012), 36% (Ricketts et al., 2015), and 22% (Sprich et 
al., 2016). The strong retention rate indicates that MCBIT treatment was acceptable to 
both participants and parents alike, and is a feasible treatment model for youths with 
CTD and co-occurring ADHD. The CSQ-Satis and CER mean scores improved from 
baseline to follow-up for both the MCBIT and CBIT groups, with no significant 
difference between groups. This demonstrates that the MCBIT treatment was as equally 
as well tolerated as traditional CBIT, and that both treatment groups had good 
expectations around treatment success. We believe that in the future, incorporating a 
remote component could improve feasibility and acceptability even further as reasons for 
drop-out, and increased time between sessions were all secondary to logistical 
difficulties.  
Of note, inclusion criteria were expanded during the study to increase enrollment 
and limit attrition. In particular, the inclusion criteria were amended to allow for 
participants with a formal clinical history of ADHD but current subclinical symptoms to 
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enroll. This is because it is common for individuals who have been treated with 
stimulants to have ongoing residual ADHD symptoms that require intervention to limit 
associated functional impairment. Allowing individuals with subclinical cases of ADHD 
to participate in the study more realistically represents the general population of those 
with CTD and co-occurring ADHD, and allows the results to be more generalizable.  
Regarding adverse events, these were broadly thought to be due to factors outside 
of the treatment protocol, including needing to reschedule due to illness, and temporary 
worsening in mood and ADHD symptom severity that did not preclude the subjects from 
continuing in the study. Additionally, given that the participant that reported worse 
symptoms and had difficulty with the treatment was in primary school, it may be helpful 
to limit participants to those at least in middle school given the content of the ADHD 
material and strategies.  
The present study offers preliminary evidence that MCBIT therapy improves tic 
severity, reduces tic-associated impairment, improves ADHD severity, and may improve 
quality of life. At EOT, there was statistically significant improvement in total tic 
severity for the MCBIT and CBIT groups taken in combination. Although the groups did 
not significantly differ from one another, these improvements were maintained and 
seemed to strengthen past EOT to three-month follow-up, particularly for the MCBIT 
group. These results indicate that MCBIT is likely at least as effective as CBIT in tic 
symptom improvement, which is important given that less time is spent focusing on tics 




There was an overall improvement in tic disorder-related impairment in both 
groups. The MCBIT group trended towards greater improvement from baseline to EOT, 
though again the groups did not significantly differ from one another. This reduction in 
impairment held steady between EOT and three-month follow-up for both groups, 
indicating that treatment effects for MCBIT persist past EOT.  
There was overall improvement in ADHD symptom severity in the CBIT group in 
addition to in the MCBIT group. Similar to both YGTSS measures, the improvement in 
ADHD severity was seen for the CBIT and MCBIT groups in combination, and the 
groups did not statistically differ from one another. These changes were maintained 
throughout follow-up in both groups; again, indicating that treatment effects persist past 
EOT. It is interesting to note that the CBIT group demonstrated improvement in ADHD 
symptoms despite not learning specific skills tailored towards addressing them. One 
possibility is that the decrease in tic severity enabled participants to experience less tic-
related distraction and thereby maintain better attention. As there is a trend towards 
ongoing ADHD improvement following EOT in the MCBIT, a hypothesis is that they 
continue to benefit from the specific ADHD treatment skills in addition over time. A 
larger follow-up study would be needed to determine any significant difference in ADHD 
symptom outcomes for MCBIT versus traditional CBIT therapy, and could also help 
clarify the degree to which ADHD is indeed a moderating factor in tic treatment 
response.  
Despite there being no significant change in child-rated quality of life measures 
(PedsQL) for either the CBIT or MCBIT groups from baseline to EOT, there was a sharp 
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increase between EOT and follow-up in both groups, with a greater trend in the MCBIT 
group. This may indicate that quality of life improvements take additional time to 
develop, and may be better captured during a longer follow-up period.  
Taken together, these results suggest that a modified model of CBIT offers an 
acceptable and feasible, and based on preliminary results, helpful alternative treatment to 
CBIT in youth with co-occurring CTD and ADHD. By incorporating specific modules 
that focus on ADHD symptoms such as limiting distractibility, improving organizational 
skills, and managing overwhelming tasks, a modified CBIT approach enables participants 
to address ADHD symptoms and tics concurrently so that both improve in tandem, and 
the improvement can be sustained (and potentially even increase) over time.  
Given the prevalence of co-occurring psychiatric conditions in those with CTD, it 
has become increasingly important to address the unique presentations of each child and 
family with personalized, adaptable treatment protocols. Recently, there has been a shift 
towards utilizing modular cognitive-behavioral therapy models, where depending on the 
specific needs and profile of the patient, individual treatment sessions can be swapped in 
or out. We utilized that approach in our MCBIT Session 10 where we only covered mood 
dysregulation/distress tolerance if there were specific concerns. if there were concerns 
about mood dysregulation or that are able to address multiple co-occurring psychiatric 
conditions and are tailored to the specific needs of the patients such as ASD and anxiety 
(Wood et al., 2014), body dysmorphic disorder (Wilhelm et al., 2011), and 
avoidant/restrictive food intake disorder (Thomas et al., 2020). Effective interventions 
exist for CTD and ADHD, but there is no established treatment to address both 
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concurrently. Modular approaches to behavioral therapy may offer greater flexibility and 
provide a method to individualize therapy to promote better treatment outcomes (Espil, 
2020).  
 
Strengths and Limitations 
 A particular strength of the current study is that patients with a large range of co-
occurring psychiatric diagnoses were included and that those participating were 
concurrently taking a variety of psychotropic medication. Given this, we believe the 
results of this study may be generalized to additional clinical settings where TS and 
PMVT are treated.  
 The greatest limitation of the current study was the sample size. Given the small 
number of participants, the power of the study was somewhat limited. A larger sample 
would be needed in order to detect statistically significant differences in the outcomes of 
the MCBIT group in comparison to the CBIT group. An additional issue that arose was 
the logistical demand that weekly fifty-five-minute sessions placed on some participants. 
Although the retention rate was strong, there was a single participant lost to follow-up 
after the parent expressed difficulty with driving into Boston to attend weekly meetings. 
Of note, the participant lost to follow-up was the sole African-American participant as 
well as the only subject whose parents’ annual income fell in the lowest income bracket 
of $25,000 - $49,000 which may restrict generalizability. Allowing for virtual visits in 
addition to the telephone encounters offered may help to alleviate this logistical burden 
and increase access to treatment for lower-income patients.  
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 Additional research is warranted to further investigate the efficacy of a MCBIT 
model of therapy for youths with tic disorders and co-occurring ADHD. Future research 
should aim to compare the efficacy of the MCBIT versus CBIT approach as well as the 
long-term maintenance of treatment gains made.   
This study presents new data on the feasibility and acceptability, as well as 
preliminary date on the efficacy of a modified treatment model of CBIT therapy. Per our 
knowledge, this is the first study to modify the standardized CBIT to target youth with 
tics and co-occurring ADHD and impaired quality of life. 
 
Conclusions 
The results of this study demonstrate preliminary evidence that a modified model 
of CBIT therapy is both feasible and acceptable for youth with co-occurring CTD and 
ADHD. In addition, the results provide preliminary support that MCBIT therapy 
improves tic severity for patients with co-occurring ADHD, and that these improvements 





Yale Global Tic Severity Scale (YGTSS; Leckman et al., 1989): The YGTSS is a 
clinician-rated scale that measures changes in tic symptom severity over time. The 
YGTSS provides a Tic Score, as well as an Impairment Score ranging between 0-50, with 
higher scores corresponding to greater tic severity and impairment. 
NICHQ Vanderbilt Assessment Scale (VAS; NICHQ, American Academy of 
Pediatrics, McNeil, 2002): The VAS is a parent (and teacher) rated scale that includes 
the DSM–IV symptom lists for ADHD and other externalizing behaviors, including 
oppositional defiant disorder (ODD) and conduct disorder (CD). VAS is rated on a four-
point scale between 0 (not at all) to 3 (very much). 
Clinical Global Impression-Improvement (CGI-Improvement; Guy, 1976): The CGI-
Improvement is a seven-point Likert scale between 0-6 corresponding to very much 
worse to very much improved, respectively. CGI may be rated by a clinician or patient.  
Clinical Global Impression-Severity (CGI-Severity; Guy, 1976): Akin to CGI-I, the 
CGI-Severity is also seven-point Likert rating indicating illness severity. Values range 
from 0-6 indicating no illness to extremely severe illness as rated by a clinician or patient.  
The Caregiver Strain Questionnaire (CSQ; Brannan et al., 1997): The Caregiver 
Strain Questionnaire measures how significantly a child’s chronic condition has 
negatively affected his or her family. Parents rate items on a zero to five scale. The 
questionnaire includes ten items that measure objective strain, and eleven items that 
assess subjective strain. 
Child Tourette's Syndrome Impairment Scale (CTIM-P; Storch et al., 2007): The 
CTIM-P is parent-rated scale that includes thirty seven items related to school, home, and 
social activities that tics may negatively impact.  
Children’s Depression Inventory (CDI): The CDI (Kovacs, 1992): is a brief self-
report (27-item) questionnaire used to assess depressive symptoms in children and 
adolescents age 7-17 years old. It has been found to have high reliability and concurrent 
validity. 
Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS; Scahill et al., 
1997): The CY-BOCS is used to measure obsessive-compulsive symptom severity over 
time with total severity scores ranging between 0 and 40. 
Client Expectancy Rating (CER; Borkovec and Nau, 1972): The Client Expectancy 
Rating assesses patients’ judgments about the credibility and acceptability of the 
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treatment, and their expectation of improvement as measured on is a four-item self-report 
scale. 
Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA; 
Gullone and Taffe, 2012): The ERQ-CA is a 10-item, valid, age-appropriate, internally 
consistent, self-administered measurement which measures the use of two specific 
emotion regulation strategies in children/adolescents aged 10-18. 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999): The WASI is a 
brief, measure of intelligence in multiple settings. It is nationally standardized, linked to 
the Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV), and in its two-
subtest form (about 15min) yields full scale IQ scores. 
Parent Tic Questionnaire (PTQ; Chang et al., 2009): The Parent Tic Questionnaire is 
rated on a 1-4 severity scale and lists twenty-eight motor and vocal tics that are marked as 
present or absent over the last week. These are summed together to generate a total score 
between 0 and 112.  
Pediatric Quality of Life Inventory-Child Version (PedsQL; Varni et al., 2003): The 
PedsQL contains twenty-three items that assesses a child’s quality of life. Items are rated 
on a five-point scale, with higher scores indicating improved quality of life.  
Client Satisfaction Questionnaire (CSQ – Satis): The Client Satisfaction Questionnaire 
is an 8 question, 4-point Likert self-report scale that measures satisfaction with treatment. 
Concomitant Medication and Therapy Questionnaire (Concom): The Concomitant 
Medication and Therapy Questionnaire tracks whether there are any concurrent therapy 
or medication changes over the course of the treatment. If yes, it is followed up by a 
Medication and/or Therapy log depending on the change. 
Likert Scales/Multiple Choice Questions: After each session, we will provide subjects 
with brief Likert scales/multiple choice questions, which they can complete at the end of 
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